PPARA and Hepatic fibrosis: Although similar anti-fibrogenic properties of synthetic PPAR-α agonists, Wy-14643 and fenofibrate, have been reported in TAA, MCD, CCl4 and ethanol-induced liver fibrosis [11, 12, 21], previous studies had not elucidated the mechanisms behind the response.